This week was all about germs, and how the tiny things living with us change as we age.
Germs 101: Viruses vs. Bacteria (Oct 26)
Bacteria are complete living cells that can split on their own. Viruses are just instructions in a protein coat that borrow your cells to copy themselves.
Read it
The Garden in Your Gut (Oct 27)
Your gut microbiome (MY-kro-BY-ohm) is like a garden that keeps changing with age, and a more varied garden tends to line up with healthier aging.
Read it
Ancient Viruses Hiding in Your DNA (Oct 28)
About 8% of your DNA is leftover notes from ancient viruses. In aging cells, some of those notes can wake back up.
Read it
Your Immune System Grows Up, Then Grows Old (Oct 29)
The thymus, where new immune “guards” train, shrinks with age, and older guards can keep a low alarm ringing called inflammaging.
Read it
Who's researching this
Seres Therapeutics is a Cambridge, Massachusetts biotech company that builds medicines out of carefully chosen gut bacteria, which it calls live biotherapeutics. Seres developed VOWST, the first FDA-approved microbiome medicine taken by mouth, and sold that business to Nestlé Health Science in 2024. Its most advanced research candidate today, SER-155, is a mix of bacteria being studied in people with weakened immune systems, such as patients getting stem cell transplants. It's still investigational, not an approved treatment. (Seres company update)
Mentioning a company is not an endorsement or medical advice.
References
- Seres Therapeutics, Second Quarter 2026 results and business update: https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-reports-second-quarter-2026-financial-results
- Seres Therapeutics, company background (SEC filing): https://www.sec.gov/Archives/edgar/data/1609809/000119312526334174/R11.htm
What this is not. Education only. Stories on cells.com are not medical advice. cells.com does not diagnose, treat, prescribe, run laboratory tests, or ship kits.
Simon Ng is the founder of cells.com. He has spent more than a decade on biotech finance executive teams, including at Quark Pharmaceuticals and Adverum Biosciences, and holds an MBA.